关注
Khalid Omer Alfarouk, PhD
Khalid Omer Alfarouk, PhD
Zamzam University College, Khartoum, Sudan
在 zamzam.edu.sd 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp
KO Alfarouk, CM Stock, S Taylor, M Walsh, AK Muddathir, D Verduzco, ...
Cancer cell international 15, 1-13, 2015
6532015
The Warburg effect and the hallmarks of cancer
L Schwartz, C T Supuran, K O Alfarouk
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2017
3512017
Glycolysis, tumor metabolism, cancer growth and dissemination. A new pH-based etiopathogenic perspective and therapeutic approach to an old cancer question
KO Alfarouk, D Verduzco, C Rauch, AK Muddathir, HHB Adil, ...
Oncoscience 1 (12), 777, 2014
2762014
Out of Warburg Effect: an effective cancer treatment targeting the tumor specific metabolism and dysregulated pH
L Schwartz, T Seyfried, KO Alfarouk, JDV Moreira, S Fais
Seminars in Cancer Biology, 2017
1272017
Tumor acidity as evolutionary spite
KO Alfarouk, AK Muddathir, MEA Shayoub
Cancers 3 (1), 408-414, 2011
1262011
The Possible Role of Helicobacter pylori in Gastric Cancer and Its Management
KO Alfarouk, AHH Bashir, AN Aljarbou, AMA Ramadan, AK Muddathir, ...
Frontiers in Oncology 9, 75, 2019
1022019
Tumor metabolism, cancer cell transporters, and microenvironmental resistance
KO Alfarouk
Journal of Enzyme Inhibition and Medicinal Chemistry 31 (6), 859-866, 2016
912016
The Pentose Phosphate Pathway Dynamics in Cancer and Its Dependency on Intracellular pH
KO Alfarouk, SBM Ahmed, RL Elliott, B A, SS Alqahtani, ME Ibrahim, ...
Metabolites 10 (285), 2020
862020
Evolution of tumor metabolism might reflect carcinogenesis as a reverse evolution process (dismantling of multicellularity)
KO Alfarouk, MEA Shayoub, AK Muddathir, GO Elhassan, AHH Bashir
Cancers 3 (3), 3002-3017, 2011
682011
Riparian ecosystems in human cancers
KO Alfarouk, ME Ibrahim, RA Gatenby, JS Brown
Evolutionary applications 6 (1), 46-53, 2013
662013
Cellular acidification as a new approach to cancer treatment and to the understanding and therapeutics of neurodegenerative diseases
S Harguindey, D Stanciu, J Devesa, K Alfarouk, RA Cardone, JDP Orozco, ...
Seminars in cancer biology 43, 157-179, 2017
652017
Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review
T Kolti, SJ Reshkin, C TMA, D DiMolfetta, MR Greco, KO Alfarouk, ...
Cancers 14 (10), 2486, 2022
512022
Vascular measurements correlate with estrogen receptor status.
M Lloyd, K Alfarouk, D Verduzco, M Bui, R Gillies, M Ibrahim, J Brown, ...
BMC Cancer 14, 279, 2014
452014
Tumor Microenvironment Features and Chemoresistance in Pancreatic Ductal Adenocarcinoma: Insights into Targeting Physicochemical Barriers and Metabolism as Therapeutic Approaches
TMA Carvalho, D Di Molfetta, MR Greco, T Koltai, KO Alfarouk, ...
Cancers 13 (23), 6135, 2021
422021
The Interplay of Dysregulated pH and Electrolyte Imbalance in Cancer
KO Alfarouk, SBM Ahmed, A Ahmed, RL Elliott, ME Ibrahim, HS Ali, ...
Cancers 12 (4), 898, 2020
422020
Of mitochondrion and COVID-19
KO Alfarouk, STS Alhoufie, A Hifny, L Schwartz, AS Alqahtani, ...
Journal of Enzyme Inhibition and Medicinal Chemistry 36 (1), 1258-1267, 2021
362021
The Role of Sodium Hydrogen Exchanger 1 in Dysregulation of Proton Dynamics and Reprogramming of Cancer Metabolism as a Sequela
RA Cardone, KO Alfarouk, RL Elliott, SS Alqahtani, SM Babikir, ...
International Journal of Molecular Sciences 20 (15), 3694, 2019
332019
Doxycycline as Potential Anti-Cancer Agent
I Ali, KO Alfarouk, SJ Reshkin, ME Ibrahim
Anti-Cancer Agents in Medicinal Chemistry, 2017
302017
Hydrogen Ion Dynamics of Cancer and a New Molecular, Biochemical and Metabolic Approach to the Etiopathogenesis and Treatment of Brain Malignancies
S Harguindey, JP Orozco, KO Alfarouk, J Devesa
International Journal of Molecular Sciences 20 (17), 4278, 2019
172019
Drug Development: Stages of Drug Development
GO Elhassa, KO Alfarouk
Journal of Pharmacovigilance 3 (3), 2015
172015
系统目前无法执行此操作,请稍后再试。
文章 1–20